{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T21:21:00Z","timestamp":1790198460291,"version":"4.1.0"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Polycystic ovary syndrome (PCOS) is a common endocrine and metabolic disorder characterized by insulin resistance, hyperandrogenism, and elevated oxidative stress. The present study aimed to investigate the synergistic therapeutic effects of metformin and curcumin on insulin resistance and oxidative stress in a rat model of PCOS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>Thirty female Sprague-Dawley rats were randomly assigned to blank control (n = 6) and experimental (PCOS) groups (n = 24). The PCOS model was induced through daily subcutaneous injections of dehydroepiandrosterone (DHEA, 60 mg\/kg) for 20 days. Subsequently, the experimental group was subdivided into four groups: PCOS-only, PCOS-metformin (300 mg\/kg), PCOS-curcumin (50 mg\/kg), and PCOS-metformin-curcumin (combined treatment). Treatments were administered daily via oral gavage for another 20 days. Estrous cycles, ovarian morphology, serum sex hormones, insulin resistance, and oxidative stress in ovarian tissues were assessed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Combined treatment with metformin and curcumin significantly restored estrous cyclicity, improved ovarian morphology, reduced serum testosterone and luteinizing hormone levels, decreased LH\/FSH ratio, and ameliorated insulin resistance compared to monotherapy groups. Moreover, the combined treatment markedly decreased ovarian oxidative stress markers (ROS and MDA) and enhanced antioxidant enzyme activities (GPx, SOD, GSH), surpassing the effects of either agent alone.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Combined administration of metformin and curcumin demonstrated synergistic therapeutic effects in PCOS rats by concurrently addressing insulin resistance and oxidative stress. These findings support the clinical potential of this combination as an effective strategy for managing PCOS. Further clinical studies are necessary to validate these promising preclinical findings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1675883","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T05:19:06Z","timestamp":1771219146000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Synergistic therapeutic effects of metformin and curcumin on polycystic ovary syndrome via regulation of insulin resistance and oxidative stress in a rat model"],"prefix":"10.3389","volume":"17","author":[{"given":"Lina","family":"Zheng","sequence":"first","affiliation":[{"name":"Department of Gynecology and Obstetrics, The First Affiliated Hospital of Chengdu Medical College","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baohua","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics, The First Affiliated Hospital of Chengdu Medical College","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junli","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pathology, The First Affiliated Hospital of Chengdu Medical College","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yianduo","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics, The First Affiliated Hospital of Chengdu Medical College","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiling","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics, The First Affiliated Hospital of Chengdu Medical College","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caifeng","family":"Deng","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics, The First Affiliated Hospital of Chengdu Medical College","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaolin","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics, The First Affiliated Hospital of Chengdu Medical College","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics, The First Affiliated Hospital of Chengdu Medical College","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dey256","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"33","author":"Teede","year":"2018","journal-title":"Hum Reprod"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e944556","DOI":"10.12659\/MSM.944556","article-title":"Lower serum ATG7 levels linked to insulin resistance in women with polycystic ovary syndrome","volume":"30","author":"Lu","year":"2024","journal-title":"Med Sci Monit"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2018.24","article-title":"Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment","volume":"14","author":"Escobar-Morreale","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2018.12.021","article-title":"Randomised controlled trial to study the efficacy of exercise with and without metformin on women with polycystic ovary syndrome","volume":"234","author":"Tiwari","year":"2019","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-020-01349-8","article-title":"Effects of oral contraceptives on serum concentrations of adipokines and adiposity indices of women with polycystic ovary syndrome: a randomized controlled trial","volume":"44","author":"Amiri","year":"2021","journal-title":"J Endocrinol Invest"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deae294","article-title":"Prospective associations of adolescent obesity phenotypes with self-reported polycystic ovary syndrome diagnosis in young adulthood","volume":"40","author":"Reich","year":"2025","journal-title":"Hum Reprod"},{"key":"B7","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1186\/s12905-024-03446-9","article-title":"Risk of polycystic ovary syndrome: a population-based analysis of sociodemographic factors, healthcare access, health behaviors, and health status","volume":"24","author":"Alenzi","year":"2024","journal-title":"BMC Womens Health"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s10815-022-02429-9","article-title":"The use of metformin in women with polycystic ovary syndrome: an updated review","volume":"39","author":"Notaro","year":"2022","journal-title":"J Assist Reprod Genet"},{"key":"B9","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1080\/09513590.2016.1236078","article-title":"Comparison of two insulin sensitizers, metformin and myo-inositol, in women with polycystic ovary syndrome (PCOS)","volume":"33","author":"Fruzzetti","year":"2017","journal-title":"Gynecol Endocrinol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1070264","article-title":"Metformin improves polycystic ovary syndrome in mice by inhibiting ovarian ferroptosis","volume":"14","author":"Peng","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B11","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/dom.16422","article-title":"Metformin use in women with polycystic ovary syndrome (PCOS): Opportunities, benefits, and clinical challenges","author":"Saadati","year":"2025","journal-title":"Diabetes Obes Metab"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1177\/2042018810380215","article-title":"Role of metformin in the management of polycystic ovary syndrome","volume":"1","author":"Lashen","year":"2010","journal-title":"Ther Adv Endocrinol Metab"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2010.11.002","article-title":"Metformin and digestive disorders","volume":"37","author":"Bouchoucha","year":"2011","journal-title":"Diabetes Metab"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1494852","article-title":"The therapeutic effects of curcumin on polycystic ovary syndrome by upregulating PPAR-gamma expression and reducing oxidative stress in a rat model","volume":"15","author":"Zhang","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_202209_29635","article-title":"Curcumin and Teupolioside attenuate signs and symptoms severity associated to hirsutism in PCOS women: a preliminary pilot study","volume":"26","author":"Malvasi","year":"2022","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S302161","article-title":"Development and evaluation of curcumin encapsulated self-assembled nanoparticles as potential remedial treatment for PCOS in a female rat model","volume":"16","author":"Raja","year":"2021","journal-title":"Int J Nanomed"},{"key":"B17","doi-asserted-by":"publisher","first-page":"256:118003","DOI":"10.1016\/j.lfs.2020.118003","article-title":"Nanocurcumin alleviates insulin resistance and pancreatic deficits in polycystic ovary syndrome rats: Insights on PI3K\/AkT\/mTOR and TNF-alpha modulations","author":"Abuelezz","year":"2020","journal-title":"Life Sci"},{"key":"B18","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s13048-023-01299-8","article-title":"Dehydroepiandrosterone-induced polycystic ovary syndrome mouse model requires continous treatments to maintain reproductive phenotypes","volume":"16","author":"Wu","year":"2023","journal-title":"J Ovarian Res"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1080\/09513590.2022.2052843","article-title":"Comparative study of DHEA and letrozole induced polycystic ovary syndrome in post-pubertal rats","volume":"38","author":"Zhang","year":"2022","journal-title":"Gynecol Endocrinol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13048-018-0427-7","article-title":"Effect of resveratrol and metformin on ovarian reserve and ultrastructure in PCOS: an experimental study","volume":"11","author":"Furat Rencber","year":"2018","journal-title":"J Ovarian Res"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.22038\/AJP.2021.55679.2785","article-title":"A comparison between the effect of trans-anethole and metformin on biochemical parameters of polycystic ovary syndrome in rats","volume":"11","author":"Moradi Negahdari","year":"2021","journal-title":"Avicenna J Phytomed"},{"key":"B22","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1301\/nr.2003.dec.397-412","article-title":"Evaluation of insulin sensitivity in clinical practice and in research settings","volume":"61","author":"Monzillo","year":"2003","journal-title":"Nutr Rev"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1042\/CS20110386","article-title":"Cellular and molecular mechanisms of metformin: an overview","volume":"122","author":"Viollet","year":"2012","journal-title":"Clin Sci (Lond)"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005552.pub3","article-title":"Metformin versus the combined oral contraceptive pill for hirsutism, acne, and menstrual pattern in polycystic ovary syndrome","volume":"8","author":"Fraison","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgad465","article-title":"Metformin and combined oral contraceptive pills in the management of polycystic ovary syndrome: A systematic review and meta-analysis","volume":"109","author":"Melin","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2024.06.037","article-title":"Comparative efficacy of metformin combined with cabergoline versus metformin alone in patients with PCOS and hyperprolactinemia: A systematic review and meta-analysis of randomized controlled trials","volume":"299","author":"Nizamani","year":"2024","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1093\/molehr\/gaaa081","article-title":"Humanin regulates oxidative stress in the ovaries of polycystic ovary syndrome patients via the Keap1\/Nrf2 pathway","volume":"27","author":"Wang","year":"2021","journal-title":"Mol Hum Reprod"},{"key":"B28","article-title":"Oxidative stress and inflammation in lean and obese subjects with polycystic ovary syndrome","volume":"58","author":"Blair","year":"2013","journal-title":"J Reprod Med"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.steroids.2011.12.003","article-title":"Inflammation in Polycystic Ovary Syndrome: underpinning of insulin resistance and ovarian dysfunction","volume":"77","author":"Gonzalez","year":"2012","journal-title":"Steroids"},{"key":"B30","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12902-023-01295-5","article-title":"The effect of Curcumin on metabolic parameters and androgen level in women with polycystic ovary syndrome: a randomized controlled trial","volume":"23","author":"Ghanbarzadeh-Ghashti","year":"2023","journal-title":"BMC Endocr Disord"},{"key":"B31","doi-asserted-by":"publisher","first-page":"106947","DOI":"10.1016\/j.prostaglandins.2024.106947","article-title":"Effect of curcumin on lipid mediators, glycemic index, and oxidative stress and inflammation biomarkers in polycystic ovary syndrome: Future directions and current knowledge - A systematic review","volume":"177","author":"Saleem","year":"2025","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"B32","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s13048-025-01660-z","article-title":"Curcumin and its formulations for the treatment of polycystic ovary syndrome: current insights and future prospects","volume":"18","author":"Mallya","year":"2025","journal-title":"J Ovarian Res"},{"key":"B33","doi-asserted-by":"publisher","first-page":"e16957","DOI":"10.1016\/j.heliyon.2023.e16957","article-title":"Potentials of curcumin against polycystic ovary syndrome: Pharmacological insights and therapeutic promises","volume":"9","author":"Akter","year":"2023","journal-title":"Heliyon"},{"key":"B34","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13098-019-0431-0","article-title":"Curcumin combined with metformin decreases glycemia and dyslipidemia, and increases paraoxonase activity in diabetic rats","volume":"11","author":"Roxo","year":"2019","journal-title":"Diabetol Metab Syndr"},{"key":"B35","doi-asserted-by":"publisher","first-page":"e12836","DOI":"10.1111\/jfbc.12836","article-title":"Combinational effect of curcumin and metformin against gentamicin-induced nephrotoxicity: Involvement of antioxidative, anti-inflammatory and antiapoptotic pathway","volume":"43","author":"Cao","year":"2019","journal-title":"J Food Biochem"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.2174\/1566524019666191016150757","article-title":"Curcumin activates the nrf2 pathway and induces cellular protection against oxidative injury","volume":"20","author":"Ashrafizadeh","year":"2020","journal-title":"Curr Mol Med"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2022.07.014","article-title":"AMPK and NRF2: Interactive players in the same team for cellular homeostasis","author":"Petsouki","year":"2022","journal-title":"Free Radic Biol Med"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3390\/molecules19068289","article-title":"A PPAR\u03b3, NF-\u03baB and AMPK-dependent mechanism may be involved in the beneficial effects of curcumin in the diabetic db\/db mice liver","volume":"19","author":"Jimenez-Flores","year":"2014","journal-title":"Molecules"},{"key":"B39","doi-asserted-by":"publisher","first-page":"100951","DOI":"10.1016\/j.ctro.2025.100951","article-title":"Regular aerobic exercise ameliorates radiation-induced pulmonary fibrosis: An animal study","volume":"53","author":"Cha","year":"2025","journal-title":"Clin Trans Radiat Oncol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1675883\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T05:19:08Z","timestamp":1771219148000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1675883\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,16]]},"references-count":39,"alternative-id":["10.3389\/fendo.2026.1675883"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1675883","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,16]]},"article-number":"1675883"}}